Endovascular Engineering (E2) announced positive safety and feasibility results from a clinical trial of its Hēlo PE ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE).

Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in ...

Prior to the introduction of intravenous heparin, surgical thrombectomy was the only effective means for treating a symptomatic lower extremity DVT, [21] but the reported outcomes of open surgical ...

New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute ...

New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV) demonstrated that ...

Late-breaking data from the ENGULF trial showed that the dual-action Helo pulmonary embolism (PE) thrombectomy system ...

Penumbra announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system.

LONG BEACH, Calif. -- Big Data may provide some answers to the many questions surrounding advanced catheter-based pulmonary ...

New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute ...